Crossmark

Notum attenuates HBV-related liver fibrosis through inhibiting Wnt 5a mediated non-canonical pathways

Crossref DOI link: https://doi.org/10.1186/s40659-019-0217-8

Published Online: 2019-03-13

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Wenting

Yu, Xiaolan

Zhu, Chuanlong

Wang, Zheng

Zhao, Zonghao

Li, Yi

Zhang, Yonghong
Funding

Funding for this research was provided by:

WBE Liver Fibrosis Foundation (CFHPC20161005)

International Cooperative Project of Anhui Province (1704e1002231)

Fundamental Research Funds for the Central Universities (WK9110000048)
License Information

Text and Data Mining valid from 2019-03-13
More Information

Article History

Received: 20 December 2017

Accepted: 21 February 2019

First Online: 13 March 2019